Stethoscope placed on a map of the United States, symbolizing nationwide healthcare and policy impact.

Across 49 States, Medically Tailored Meals Could Save Millions: State-Level Modeling

Food-as-Medicine • Policy & Economics

A new Health Affairs simulation suggests medically tailored meals (MTMs) would be net cost-saving in nearly every U.S. state — even after implementation costs. Here’s what this means for physicians, payers, and policymakers.

Quick take for physicians: According to Health Affairs (2025) state-level modeling, scaling medically tailored meals (MTMs) for adults with diet-sensitive conditions could reduce hospitalizations and generate net savings across most states.For clinicians, the takeaway is clear: MTMs are no longer just a clinical intervention — they’re a proven value-based care lever with state-level cost-effectiveness data to back implementation.


Study Overview

Design: State-by-state simulation using national and state data to model MTM eligibility, baseline utilization, and health expenditures.
Objective: Compare program costs (meals, screening, admin) with medical savings from reduced hospitalizations and complications.
Time Horizon: Multi-year projections under conservative and moderate adoption scenarios.
Cohort: Adults with diet-sensitive chronic conditions and functional barriers to meal preparation.


Key Finding

  • Net cost savings in most states: 48 of 49 modeled states achieved net savings even after MTM program costs.
  • Hospitalizations averted: Reduced inpatient utilization accounted for the majority of savings.
  • Robust across assumptions: Savings persisted under conservative estimates of adherence and pricing.
  • Policy impact: Findings support inclusion of MTMs in Medicaid waivers, MA supplemental benefits, and state social needs programs.

MTMs aren’t just an equity initiative — they’re an evidence-based cost reducer.
The modeling demonstrates financial viability across diverse markets, making it easier for payers to justify coverage and for physicians to advocate for inclusion in discharge pathways or care bundles.

Expect expanding coverage via:

  • Medicaid 1115/1915 waivers
  • Medicare Advantage supplemental benefits
  • Employer-based and value-based contracts

Clinician Playbook: How to Act Now

Screen: Identify adults with cardiometabolic conditions and food insecurity or IADL limitations.
Prescribe: 7–14 meals/week for 8–12 weeks post-discharge or during therapy changes.
Coordinate: Integrate RD check-ins every 2–4 weeks to reinforce sodium, protein, and satiety strategies.
Track: Admissions, ED visits, diet quality, BP, and patient-reported adherence.
Document: Utilization and outcomes for value-based contract validation.


Key Findings

  • Medicaid Waivers: Fund MTMs for high-risk populations via 1115 or 1915 waivers under health-related social needs benefits.
  • Medicare Advantage: Offer MTMs as part of chronic condition supplemental benefits.
  • Employer/VBC Programs: Bundle MTMs within episodes or advanced primary care contracts.
  • Evaluation: Require consistent outcomes tracking and independent validation for local ROI.


FAQs

Which patients qualified in the model?
Adults with diet-sensitive chronic conditions (diabetes, CVD, renal disease) and barriers to meal prep — e.g., food insecurity or IADL limitations.

How long should MTM coverage last?
Typically 8–12 weeks at 7–14 meals/week, extendable based on adherence, risk, and outcomes.

What outcomes should be monitored?
30-/90-day readmissions, ED visits, weight/BP, diet quality, and patient persistence; some payers add adherence or function metrics.

Related articles

Stethoscope placed on a map of the United States, symbolizing nationwide healthcare and policy impact.

Across 49 States, Medically Tailored Meals Could Save Millions: State-Level Modeling

Health Affairs: MTMs could save costs in nearly every state—implications for physicians, payers, and policymakers.

Read more

Does Meal “Dose” Matter in Heart Failure? The MEDIMEALS Trial (7 vs 21 Meals/Week)

Post-discharge heart failure trial: MTMs improve nutrition, diet adherence, and sarcopenia risk—7 vs 21 meals/week similar.

Read more

Beyond GLP-1s: How Food-as-Medicine Can Improve Outcomes and Bend the Cost Curve

GLP-1s deliver strong outcomes, but high costs; pairing with MTMs can sustain results, improve adherence, and control spend.

Read more

Help Scale Food-as-Medicine in Your State

Prado enables physicians to prescribe medically tailored meals with HSA/FSA support, dietitian touchpoints, and outcomes dashboards — built for payer alignment and value-based contracts.

Stethoscope placed on a map of the United States, symbolizing nationwide healthcare and policy impact.